Equibles does not estimate personal net worth.
Get an email with a short summary when PROCEPT BioRobotics Corp publishes a filing, an earnings call transcript or a press release.
Get PRCT alertsReza Zadno is recorded as CEO at PROCEPT BioRobotics Corp (PRCT). The newest filing on record that lists Reza Zadno as CEO at PROCEPT BioRobotics Corp (PRCT) is dated April 22, 2026. PROCEPT BioRobotics Corp reported in an 8-K filed July 25, 2025 that Reza Zadno retired as President, CEO, and director, effective September 1, 2025. The proxy statement of PROCEPT BioRobotics Corp reports total compensation of $6,766,276 for Reza Zadno in fiscal 2025, including a base salary of $471,306. Disclosed compensation is on record for 6 fiscal years. Reza Zadno has spoken on 16 earnings calls across 1 company, most recently for PROCEPT BioRobotics Corp on August 6, 2025. PROCEPT BioRobotics Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at PROCEPT BioRobotics Corp includes Larry L. Wood (CEO and Board Member), Larry Wood (CEO), Thomas M. Prescott (Chairman and Board Member) and 7 others.
“Dr. Reza Zadno will retire as president, CEO, and director effective September 1, 2025.”
“Before we review our second quarter results and provide an update on our outlook for 2025, I'd like to share a few brief remarks on our progress and welcome Larry Wood to PROCEPT.”
“And a general business update followed by Sham, who will provide the commercial overview. Lastly, Kevin will provide additional detail regarding our financial performance and updated 2025 financial guidance.”
“For today's call, I will provide opening comments and a general business update, followed by Sham, who will provide an overview of the HYDROS Robotic Systems commercial launch and fourth quarter procedure trends.”
“For today's call, I will provide opening comments and a general business update followed by Sham, who will provide an overview of the HYDROS Robotic Systems commercial launch.”
“For today's call, I will provide opening comments and a general business update, followed by Kevin who will then provide additional detail regarding our financial performance and updated 2024 guidance.”
Start not stated–present
Last confirmed April 22, 2026
2020-01-01–2025-04-25
Last confirmed by a filing; no departure on record
Start not stated–2025-09-01
Medical Devices · Healthcare
CEO
2020-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | PROCEPT BioRobotics Corp (PRCT) | Ph.D., Former President & Chief Executive Officer | $471,306 | $6,766,276 |
| 2024 | PROCEPT BioRobotics Corp (PRCT) | Ph.D., President & Chief Executive Officer | $671,900 | $6,521,876 |
| 2023 | PROCEPT BioRobotics Corp (PRCT) | Ph.D., President & Chief Executive Officer | $612,575 | $6,088,813 |
| 2022 | PROCEPT BioRobotics Corp (PRCT) | Ph.D., President & Chief Executive Officer | $575,000 | $4,131,452 |
| 2021 | PROCEPT BioRobotics Corp (PRCT) | Ph.D., President & Chief Executive Officer | $490,000 | $1,374,745 |
| 2020 | PROCEPT BioRobotics Corp (PRCT) | Ph.D., President & Chief Executive Officer | $435,417 | $3,555,435 |
